NCT03339531View on ClinicalTrials.gov

Optimized 2D-RT for Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

December 18, 2015

Study Completion Date

December 18, 2015

Conditions

Prostate Cancer

Interventions

RADIATION

2D radiotherapy

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT03339531 - Optimized 2D-RT for Prostate Cancer | Biotech Hunter | Biotech Hunter